期刊论文详细信息
Cells
ELISPOT Refinement Using Spot Morphology for Assessing Host Responses to Tuberculosis
Laura S. Sibley1  Andrew D. White1  Alice Marriott1  Michael J. Dennis1  Ann Williams1  Philip D. Marsh1 
[1] Microbiological Services, Health Protection Agency Porton, Porton Down, Salisbury, Wiltshire SP4 0JG, UK;
关键词: ELISPOT;    IFNγ;    tuberculosis;    BCG;   
DOI  :  10.3390/cells1010005
来源: mdpi
PDF
【 摘 要 】

Tuberculosis is a global health problem. The Mycobacterium bovis Bacille Calmette Guerin (BCG) vaccine has variable efficacy (0-80%) so there is a drive to develop novel vaccines. The cytokine, interferon gamma (IFNγ), is an essential component of the protective response to M. tuberculosis (M. tb) infection and is also produced in response to BCG vaccination. Induction of an IFNγ response is used as a biomarker of successful vaccination in the assessment of new tuberculosis (TB) vaccines. The IFNγ ELISPOT assay provides an important tool for TB research. It is used for both the diagnosis of infection (T.Spot assay), and for the evaluation of the immunogenicity of new TB vaccine candidates in human clinical trials, in the non-human primate (NHP) model of TB infection studies. The ELISPOT assay captures IFNγ produced by peripheral blood mononuclear cells (PBMCs) following specific stimulation, onto a membrane so individual cells can be enumerated and the frequency of responding cells determined. Hence spot forming units (SFU) per 106 cells provide the traditional measure for ELISPOT assays. The discriminatory power of SFU is limited. In some situations, the number of SFU in BCG vaccinated, and unvaccinated, subjects was found to be similar, although the spots were observed to be larger in vaccinated subjects. Spot size potentially provides a measure of the quantity of cytokine produced by individual cells. The AID ELISPOT plate reader software used to determine frequency of spots also has the capability to determine the size of each spot. Consideration of spot size in combination with spot forming units was investigated in our studies of BCG immunogenicity. This additional readout was found to enhance the discriminatory power of the ELISPOT assay, and provide more information on the immune response to BCG vaccination and infection with M.tb.

【 授权许可】

CC BY   
© 2012 by the authors; licensee MDPI, Basel, Switzerland.

【 预 览 】
附件列表
Files Size Format View
RO202003190045360ZK.pdf 235KB PDF download
  文献评价指标  
  下载次数:13次 浏览次数:31次